fashion -WSS

fashion

author：leisure time 2025-10-01 11:35:26 - browse：545

Matts Take Column Illustration — Molly Ferguson for STAT

If you’re a drug company executive, you probably feel like you got up on the wrong side of bed.

On Thursday night, President Biden proposed expanding one of his most popular policies: the Medicare price negotiation process that was put in place as part of the Inflation Reduction Act. “Americans pay more for prescription drugs than anywhere else,” Biden said. “It’s wrong and I’m ending it.”

Obviously, the drug industry is not going to be happy about new price limitations in the U.S., the biggest market for pharmaceuticals. But, even more than that, Biden’s move emphasizes a painful reality: That pharmaceutical companies remain one of the biggest political targets in the country — despite their key role in addressing the Covid-19 pandemic and their development of wildly effective new weight loss drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： ASCO: Palliative care found as helpful given virtually as in person

WSS

Woman returns to dialysis after doctors remove transplanted pig kidney

Prime Medicine, Myeloid Therapeutics clash over genome

In Spain, a hospital brews its own CAR

HCA sued by state AG for quality issues at Mission Health

Virtual care provider acquires bankrupt Pear's prescription apps

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

explore

fashion

hotspot

Walensky prepares to leave CDC — and Congress — behind

Carvykti CAR

Drug repurposing or repositioning? The language matters

Change Healthcare can notify patients about the breach, HHS says

Moonlake's readout produced a cash windfall. Risks remain

ASCO: AstraZeneca says CAR

ChatGPT in medicine: STAT answers readers' burning questions

Can sheer will power keep patients alive in their dying hours?

Sports medicine is finally prioritizing gender equality

Why health care costs have stayed mostly flat since 2010

hotspot

SNAP should offer more nutrition education

CRISPR gene editing developments we’re watching in 2024

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Let's speed up science by embracing open access publishing

Three trends to watch in biotech in 2024

Prime Medicine, Myeloid Therapeutics clash over genome

hotspot

focus

entertainment

focus